Skip to search formSkip to main contentSkip to account menu

Botulinum Toxin Type A

Known as: Clostridium Botulinum Toxin Type A, BoNT/A, Botulinum Toxins, Type A 
An injectable formulation of a neurotoxin derived through the fermentation of the Hall strain of Clostridium botulinum type A with neuromuscular… 
National Institutes of Health

Related topics

Related topics

42 relations
Anal FissureBlepharospasmBotulinum Toxin Type A InjectionClostridium botulinum toxin A Ab:PrThr:Pt:Ser:Ord

Narrower (13)

BotoxDWP450DysportHengli BTX-A

Broader (3)

Botulinum ToxinsNeuromuscular AgentsNeurotoxins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Advances in Facial Rejuvenation: Botulinum Toxin Type A, Hyaluronic Acid Dermal Fillers, and Combination Therapies–-Consensus Recommendations
Background: Facial aesthetics and rejuvenation are evolving rapidly due to changes in products, procedures, and patient… 
Highly Cited
2005
Highly Cited
2005
Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity.
PURPOSE Botulinum neurotoxin type A (BoNT/A) is effective in the treatment of intractable detrusor overactivity (DO). In addition… 
Highly Cited
2005
Highly Cited
2005
A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia
A new botulinum toxin type A free of complexing proteins (NT 201) was compared with BOTOX in patients with cervical dystonia by… 
Review
2004
Review
2004
Development of resistance to botulinum toxin type A in patients with torticollis
Between 1984 and 1992, 559 patients with torticollis were treated with botulinum toxin type A (btx) injections. Twenty‐four of… 
Review
2004
Review
2004
Consensus recommendations on the use of botulinum toxin type a in facial aesthetics.
The use of botulinum toxin type A for facial enhancement is the most common cosmetic procedure currently undertaken in the United… 
Review
2003
Review
2003
Evidence for Antinociceptive Activity of Botulinum Toxin Type A in Pain Management
The neurotoxin, botulinum toxin type A, has been used successfully, in some patients, as an analgesic for myofascial pain… 
Highly Cited
2002
Highly Cited
2002
A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.
BACKGROUND Botulinum toxin type A (BTX-A) is widely used for facial esthetics but is incompletely studied. OBJECTIVE This study… 
Highly Cited
2000
Highly Cited
2000
Botulinum Toxin Type A as a Migraine Preventive Treatment
Objective.—To assess the safety and efficacy of botulinum toxin type A (BOTOX; Allergan, Inc) in the prevention of migraine. 
Highly Cited
2000
Highly Cited
2000
Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open-label study
ABSTRACT OBJECTIVE: The object of this clinical experience was to evaluate the correlation between pericranial botulinum toxin… 
Highly Cited
1998
Highly Cited
1998
Crystal structure of botulinum neurotoxin type A and implications for toxicity
Botulinum neurotoxin type A (BoNT/A) is the potent disease agent in botulism, a potential biological weapon and an effective… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)